Cover Image
市場調查報告書

Proteologics Ltd. - 產品平台分析

Proteologics Ltd. - Product Pipeline Review - 2014

出版商 Global Markets Direct 商品編碼 276029
出版日期 內容資訊 英文 20 Pages
訂單完成後即時交付
價格
Back to Top
Proteologics Ltd. - 產品平台分析 Proteologics Ltd. - Product Pipeline Review - 2014
出版日期: 2014年07月31日 內容資訊: 英文 20 Pages
簡介

Proteologics Ltd.是活用泛素系統來研究開發劃時代治療藥的生物製藥公司。該公司提供各種類型的癌症和代謝性疾病,病毒感染疾病,中樞神經系統相關疾病等所用的新藥劑標的,擁有以泛素系統為首,各種發現及驗証標的、研發藥物及開發等技術。

本報告提供Proteologics Ltd.的治療藥開發平台現狀及各開發階段比較分析,彙整藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Proteologics Ltd.的基本資料

Proteologics Ltd.概要

  • 主要資訊
  • 企業資料

Proteologics Ltd.:R&D概要

  • 主要的治療範圍

Proteologics Ltd.:開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品

Proteologics Ltd.:開發中產品概況

  • 初期階段產品開發中產品
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

Proteologics Ltd.:藥物簡介

  • Small Molecule to Inhibit Midline-1
  • Drug to Inhibit Ubiquitin Ligase for Cancer

Proteologics Ltd.:開發平台分析

  • 標的別
  • 各分子類型
  • 各作用機制

Proteologics Ltd.:最近的開發平台趨勢

Proteologics Ltd.:暫停中的計劃

Proteologics Ltd.:總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC05785CDB

Summary

Global Markets Direct's, 'Proteologics Ltd. - Product Pipeline Review - 2014', provides an overview of the Proteologics Ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Proteologics Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Proteologics Ltd. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Proteologics Ltd.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Proteologics Ltd.'s pipeline products

Reasons to buy

  • Evaluate Proteologics Ltd.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Proteologics Ltd. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Proteologics Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Proteologics Ltd. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Proteologics Ltd.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Proteologics Ltd. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Proteologics Ltd. Snapshot
    • Proteologics Ltd. Overview
    • Key Information
    • Key Facts
  • Proteologics Ltd. - Research and Development Overview
    • Key Therapeutic Areas
  • Proteologics Ltd. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Proteologics Ltd. - Pipeline Products Glance
    • Proteologics Ltd. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Proteologics Ltd. - Drug Profiles
    • Small Molecule to Inhibit Midline-1
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Drug to Inhibit Ubiquitin Ligase for Cancer
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Proteologics Ltd. - Pipeline Analysis
    • Proteologics Ltd. - Pipeline Products by Target
    • Proteologics Ltd. - Pipeline Products by Molecule Type
    • Proteologics Ltd. - Pipeline Products by Mechanism of Action
  • Proteologics Ltd. - Recent Pipeline Updates
  • Proteologics Ltd. - Dormant Projects
  • Proteologics Ltd. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Proteologics Ltd., Key Information
  • Proteologics Ltd., Key Facts
  • Proteologics Ltd. - Pipeline by Indication, 2014
  • Proteologics Ltd. - Pipeline by Stage of Development, 2014
  • Proteologics Ltd. - Monotherapy Products in Pipeline, 2014
  • Proteologics Ltd. - Preclinical, 2014
  • Proteologics Ltd. - Discovery, 2014
  • Proteologics Ltd. - Pipeline by Target, 2014
  • Proteologics Ltd. - Pipeline by Molecule Type, 2014
  • Proteologics Ltd. - Pipeline Products by Mechanism of Action, 2014
  • Proteologics Ltd. - Recent Pipeline Updates, 2014
  • Proteologics Ltd. - Dormant Developmental Projects,2014
  • Proteologics Ltd., Other Locations

List of Figures

  • Proteologics Ltd. - Pipeline by Top 10 Indication, 2014
  • Proteologics Ltd. - Pipeline by Stage of Development, 2014
  • Proteologics Ltd. - Monotherapy Products in Pipeline, 2014
  • Proteologics Ltd. - Pipeline by Top 10 Target, 2014
  • Proteologics Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2014
Back to Top